Apple Stores in the United States have resumed sales of the Apple Watch Series 9 and Apple Watch Ultra 2 after a temporary pause. The two models had faced a ban over a disputed blood oxygen feature, which medical device-maker Masimo claimed Apple infringed upon. Apple had hoped for a veto on the ITC order from US President Biden, but the veto was not pursued, leading to the ban being put into effect. Apple appealed against the ruling at the Federal Courts of Appeal for a stay, which has been approved. The court has granted Apple permission to sell its watches temporarily while the appeal is considered. The online sales of the watch models are scheduled to resume soon. Apple has stated that it is pleased with the court’s decision and that it will continue to work towards resolving the patent dispute. The ITC opposes the halt of its order, arguing that Apple did not face irreparable harm during the appeal period. The court will determine whether to enforce a ban on the sale of the watches or to delay it until the patent dispute is resolved.